A new role for GABA: Inhibition of tumor cell migration

Trends in Pharmacological Sciences

Volumn 24, Issue 4, 2003, Pages 151-154

  Ortega, Arturo ^a  

^a Cinvestav Campus Zacatenco   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR; BACLOFEN; IONOTROPIC RECEPTOR; METABOTROPIC RECEPTOR;

ACROSOME; CANCER INVASION; CARCINOGENESIS; CELL MIGRATION; COLON CARCINOMA; DRUG EFFECT; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR SENSITIVITY; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION; TUMOR GROWTH;

EID: 0037388306     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(03)00052-X     Document Type: Review

References (20)

1. Bormann J. The 'ABC' of GABA receptors. Trends Pharmacol. Sci. 21:2000;16-19.
2. B receptors. Trends Neurosci. 24:2001;277-282.
3. Watanabe M., et al. GABA and GABA receptors in the central nervous system and other organs. Int. Rev.Cytol. 213:2002;1-47.
4. B receptors in the lung. Trends Pharmacol. Sci. 14:1993;26-29.
5. B receptor in rat testis and sperm. Biochem. Biophys. Res. Commun. 283:2001;243-247.
6. Opolski A., et al. The role of GABAergic system in human mammary gland pathology and in growth of transplantable murine mammary cancer. J. Exp. Clin. Cancer Res. 19:2000;383-390.
7. Kleinrok Z., et al. GABA content and GAD activity in colon tumors taken from patients with colon cancer or from xenografted human colon cancer cells growing as S.C.tumors in a thymic nu/nu mice. J. Physiol. Pharmacol. 49:1998;303-310.
8. Minuk G.Y. GABA and hepatocellular carcinoma. Mol. Cell. Biochem. 207:2000;105-108.
9. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 12:2000;121-127.
10. Entschladen F., et al. Neurotransmitters are regulators for the migration of tumor cells and leukocytes. Cancer Immunol. Immunother. 51:2002;467-482.
11. Müller A., et al. Involvement of chemokine receptors in beast cancer metastasis. Nature. 410:2001;50-56.
12. Entschladen F., Zänker K.S. Locomotion of tumor cells: a molecular comparison to migrating pre- and postmitotic leukocytes. J. Cancer Res. Clin. Oncol. 126:2000;671-681.
13. Tatsuta M., et al. Inhibition by γ-amino-n-butyric acid and baclofen of gastric carcinogenesis induced by N-methyl-N′-nitro-N-nitrosguanidine in Wistar rats. Cancer Res. 50:1990;4931-4934.
14. Tatsuta M., et al. Attenuation by the GABA receptor agonist baclofen of experimental carcinogenesis in rat colon by azoxymethane. Oncology. 49:1992;241-245.
15. Nicholson C.S., et al. Urine GABA levels in ovarian cancer patients: elevated GABA in malignancy. Cancer Lett. 162:2001;27-30.
16. Mazurkiewicz M. GABA level and GAD activity in human and mouse normal and neoplastic mammary gland. J. Exp. Clin. Res. 18:1999;247-253.
17. Joshep J., et al. The neurotransmitter gamma aminobutyric acid is an inhibitory regulator for the migration of SW480 colon carcinoma cells. Cancer Res. 62:2002;6467-6469.
18. Masur K., et al. Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by β-blockers. Cancer Res. 61:2001;2866-2869.
19. Kiley S.C., et al. Protein kinase C delta involvement in mammary tumor cell metastasis. Cancer Res. 59:1999;3230-3238.
20. Oliver C.J., Shenolikar S. Physiologic importance of protein phosphatase inhibitors. Front. Biosci. 3:1998;961-972.